Browsing by Author López-Cortés, Luis F

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
PreviewTitleAuthor(s)Issue Date
Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy.Neukam, Karin; Munteanu, Daniela I; Rivero-Juárez, Antonio; Lutz, Thomas; Fehr, Jan; Mandorfer, Mattias; Bhagani, Sanjay; López-Cortés, Luis F; Haberl, Annette; Stoeckle, Marcel; Márquez, Manuel; Scholten, Stefan; de Los Santos-Gil, Ignacio; Mauss, Stefan; Rivero, Antonio; Collado, Antonio; Delgado, Marcial; Rockstroh, Juergen K; Pineda, Juan A29-Apr-2015
Clinical and Virological Efficacy of Etravirine Plus Two Active Nucleos(t)ide Analogs in an Heterogeneous HIV-Infected Population.López-Cortés, Luis F; Viciana, Pompeyo; Girón-González, José A; Romero-Palacios, Alberto; Márquez-Solero, Manuel; Martinez-Perez, Maria A; López-Ruz, Miguel A; Torre-Lima, Javier de la; Téllez-Pérez, Francisco; Delgado-Fernández, Marcial; Garcia-Lázaro, Milagros; Lozano, Fernando; Mohamed-Balghata, Mohamed O16-May-2014
Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens.López-Cortés, Luis F; Castaño, Manuel A; López-Ruz, Miguel A; Rios-Villegas, María J; Hernández-Quero, José; Merino, Dolores; Jiménez-Aguilar, Patricia; Marquez-Solero, Manuel; Terrón-Pernía, Alberto; Tellez-Pérez, Francisco; Viciana, Pompeyo; Orihuela-Cañadas, Francisco; Palacios-Baena, Zaira; Vinuesa-Garcia, David; Fajardo-Pico, Jose M; Romero-Palacios, Alberto; Ojeda-Burgos, Guillermo; Pasquau-Liaño, Juan12-Feb-2016
Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study.López-Cortés, Luis F; Viciana, Pompeyo; Ruiz-Valderas, Rosa; Pasquau, Juan; Ruiz, Josefa; Lozano, Fernando; Merino, Dolores; Vergara, Antonio; Terrón, Alberto; González, Luis; Rivero, Antonio; Muñoz-Sanz, Agustin17-Mar-2010
Influence of IL28B polymorphisms on response to a lower-than-standard dose peg-IFN-α 2a for genotype 3 chronic hepatitis C in HIV-coinfected patients.López-Cortés, Luis F; Ruiz-Valderas, Rosa; Jimenez-Jimenez, Luis; González-Escribano, María F; Torres-Cornejo, Almudena; Mata, Rosario; Rivero, Antonio; Pineda, Juan A; Marquez-Solero, Manuel; Viciana, Pompeyo3-Jan-2012
Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection.Macías, Juan; López-Cortés, Luis F; Téllez, Francisco; Recio, Eva; Ojeda-Burgos, Guillermo; Ríos, Maria José; Rivero-Juárez, Antonio; Delgado, Marcial; Rivas, Jeremías; Pineda, Juan A7-Dec-2015
Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients: A multicenter study.Falcon-Neyra, Lola; Palladino, Claudia; Navarro Gómez, María Luisa; Soler-Palacín, Pere; González-Tomé, María Isabel; De Ory, Santiago J; Frick, Marie Antoinette; Fortuny, Clàudia; Noguera-Julian, Antoni; Bermúdez Moreno, Elena; Santos, Juan Luis; Olbrich, Peter; López-Cortés, Luis F; Briz, Verónica; Neth, OlafJun-2016